Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-10-18 Purchase | 2023-10-31 07:08 am | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. 10% Owner | 1,317,716 | $0 | $0 | 1,094,091 (Indirect) | View |
| 2020-05-12 Purchase | 2020-05-14 4:41 pm | Ayala Pharmaceuticals Inc. | AYLA | Israel Biotech Fund I L.P. 10% Owner | 225,000 | $15 | $3,375,000 | 3,315,119 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Exercise | 2024-03-06 07:13 am | 2023-11-17 N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 15,000,000 | $0 | 51,900,000 (Indirect) | View |
| 2024-02-07 Exercise | 2024-02-12 2:16 pm | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 27,847,159 | $0.4 | 105,571,313 (Indirect) | View |
| 2024-02-07 Tax Withholding | 2024-02-12 2:16 pm | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 5,294,486 | $1.2465 | 105,571,313 (Indirect) | View |
| 2024-02-07 Exercise | 2024-02-12 2:16 pm | 2023-11-17 2028-11-17 | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund II L.P. Israel Biotech Fund GP Partners L.P. Israel Biotech Fund GP Partners II L.P. I.B.F. Management Ltd. Director 10% Owner | 27,847,159 | $0 | 105,571,313 (Indirect) | View |
Ownership(A) | 2023-09-29 06:10 am | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. Israel Biotech Fund GP Partners L.P. I.B.F. Management Ltd. 10% Owner | 0 | $0 | 621,253 (Indirect) | View |
Ownership | 2023-09-11 12:41 pm | N/A N/A | Ayala Pharmaceuticals Inc. | ADXS | Israel Biotech Fund I L.P. 10% Owner | 0 | $0 | 621,253 (Indirect) | View |
| 2020-05-12 Conversion | 2020-05-14 4:41 pm | N/A N/A | Ayala Pharmaceuticals Inc. | AYLA | Israel Biotech Fund I L.P. 10% Owner | 1,742,964 | $0 | 3,315,119 (Direct) | View |
Ownership | 2020-05-07 7:40 pm | N/A N/A | Ayala Pharmaceuticals Inc. | AYLA | Israel Biotech Fund I L.P. 10% Owner | 0 | $0 | 3,090,119 (Direct) | View |